Mirtazapine 15mg""''""'

Mirtazapine

MIRTAZPRIME   is a medication primarily used as an antidepressant. It belongs to a class of drugs known as tetracyclic antidepressants, although it is often categorized as an atypical antidepressant due to its unique pharmacological profile. MIRTAZPRIME  is prescribed to treat major depressive disorder (MDD) and has also been used off-label for various other conditions.

MIRTAZPRIME  works by increasing the levels of certain neurotransmitters in the brain, particularly norepinephrine and serotonin. It does this by blocking certain receptors (alpha-2 adrenergic receptors) that inhibit the release of these neurotransmitters. Additionally, it has antihistamine properties, which can cause sedation.

1. MIRTAZPRIME  is primarily prescribed for the treatment of major depressive disorder (depression). It is also sometimes used off-label for other conditions, such as anxiety disorders, insomnia, and post-traumatic stress disorder (PTSD). It can be particularly useful in cases where insomnia is a symptom of depression.

2.  The dosage of MIRTAZPRIME  can vary depending on the individual's condition and response to the medication. It is usually taken orally in the form of tablets or orally disintegrating tablets. The typical starting dose for depression is 15 mg per day, taken at bedtime. However, dosages can range from 15 mg to 45 mg daily.

3. Common side effects of MIRTAZPRIME  may include drowsiness, increased appetite, weight gain, dry mouth, constipation, and dizziness. Some people may also experience less common side effects like vivid dreams, confusion, or changes in blood pressure.

4. Like many antidepressants, MIRTAZPRIME  should not be discontinued abruptly. Tapering off the medication under medical supervision is usually recommended to minimize withdrawal symptoms.

5. Before taking MIRTAZPRIME   it's important to inform your healthcare provider about any other medications you are taking, as well as any pre-existing medical conditions. It may not be suitable for individuals with certain health issues, such as narrow-angle glaucoma or a history of seizures.

6. Patients taking MIRTAZPRIME   should be monitored regularly by a healthcare professional, especially during the initial weeks of treatment, to assess the effectiveness of the medication and monitor for side effects.

7. For further information please contact:

   info@sterispharma.com

   Order Now - https://www.sterisonline.com/product/mirtazprime-15-133586